GRAPPA ‐OMERACT consensus‐based recommendations and research agenda for use of composite measures and treatment targets in PsA

ConclusionsConsensus was not reached on a continuous measure of disease activity. In the interim the group recommends several composites. Consensus was reached on a treatment target of VLDA/MDA. An extensive research agenda was composed and recommends that data on all PsA clinical domains be collected in ongoing studies.This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fart.40391

Source: Arthritis and Rheumatism - November 28, 2017 Category: Rheumatology Authors: Laura C Coates, Oliver FitzGerald, Joseph F. Merola, Josef Smolen, Leonieke J. J. van Mens, Heidi Bertheussen, Wolf ‐Henning Boehncke, Kristina Callis Duffin, Willemina Campbell, Maarten de Wit, Dafna Gladman, Alice Gottlieb, Jana James, Arthur Kavanaug Tags: Full Length Source Type: research